Allergan Aesthetics / Envy Medical
DiamondGlow
A branded superficial facial procedure using a reusable diamond tip, suction, and simultaneous delivery of topical Pro-Infusion solutions.
Diamond-tip dermabrasion with suction and topical infusionReviewed 7/30/2026Source recorded
At a glance
| Primary purpose | Temporary surface exfoliation, extraction, and topical infusion for smoother, brighter-looking skin. |
|---|---|
| Mechanism | A diamond-tip handpiece abrades the superficial stratum corneum while suction removes debris and the device delivers a selected topical solution. |
| When results appear | Surface cosmetic change is assessed immediately after treatment. |
| Typical sessions | One session for temporary surface improvement; repeat treatments are elective and durability is not established here. |
| Downtime | Usually no planned downtime, although redness, sensitivity, abrasion, suction marks, or reaction to topical products can occur. |
| Reversibility | Superficial exfoliation is not reversible; the cosmetic hydration effect is temporary. |
| Documented risks | Irritation, erythema, abrasion, suction marks, infection if hygiene is inadequate, and reactions to topical solutions; contraindications in the user manual must be followed. |
| Most common disappointment | A polished immediate appearance is temporary and does not correct deep wrinkles, laxity, muscle pull, or volume loss. |
| Common marketing misconception | Topical infusion during dermabrasion is not injectable delivery into deep tissue. |
| What varies by provider | Diamond-tip grit, suction, passes, pressure, solution choice, hygiene, and skin-barrier assessment. |
| Skin-tone considerations | Aggressive abrasion can provoke post-inflammatory pigment change in susceptible skin; conservative technique and barrier assessment matter. |
| When this treatment may not be appropriate | When there is active infection, open or compromised skin, significant inflammatory disease, solution allergy, or a goal requiring deeper treatment. |
| United States regulatory status | The underlying SilkPeel/Dermalinfusion powered-dermabrasion device family is FDA-listed as Class I under product code GFE and described in FDA records as 510(k)-exempt; this is not FDA approval of every DiamondGlow cosmetic claim. |
| Canadian regulatory status | No DiamondGlow-named Class II–IV active MDALL licence was identified. Class I devices do not receive an MDALL device licence, so Canadian establishment and model status require separate verification. |
| Evidence status | Moderate for device process and immediate surface effects; limited for durable outcomes, and no longevity claim is published. |
Sources
- DiamondGlow — how the treatment works (manufacturer)manufacturer · manufacturer documentation · supports 15 profile fields
- DiamondGlow — treatment overview (manufacturer)manufacturer · manufacturer documentation
- DiamondGlow Frequently Asked Questionsofficial manufacturer information · manufacturer-primary · supports 9 profile fields
- FDA Establishment Registration and Device Listing: Envy Medical powered dermabrasion devicesFDA device listing · regulatory-primary · supports 2 profile fields
- FDA MAUDE report identifying SilkPeel Pro Dermalinfusion as 510(k)-exemptFDA device adverse-event record · regulatory-primary
- Health Canada Medical Devices Active Licence ListingHealth Canada regulatory guidance · regulatory-primary
Related comparisons
See average treatment prices near you
Enter a US ZIP code or Canadian postal code to check our stored estimate for the surrounding market.